<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="5ad67ea2-409c-4f52-a9b8-38216209609a"><labelDrug name="Mavik"><Normalization><mmtx cui="C0721596" preferredWord="Mavik" semType="phsu, orch"/></Normalization></labelDrug><generic name="Trandolapril"/><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.1" text="MAVIK (trandolapril) tablet" type="negative"><entity charOffset="0:5" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.1.e.0" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="7:19" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.1.e.1" text="trandolapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0076891" phraseText="(trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.1.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.1.e.1"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2" text="Trandolapril is the ethyl ester prodrug of a nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor, trandolaprilat." type="negative"><entity charOffset="0:12" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.0" text="trandolapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0076891" phraseText="Trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="59:104" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.1" text="angiotensin converting enzyme inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3536837" phraseText="the ethyl ester prodrug of a nonsulfhydryl angiotensin converting enzyme (ACE) inhibitor," preferredWord="Angiotensin Converting Enzyme Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="106:120" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.2" text="trandolaprilat" type="Biomedical_Entity"><Normalization><mmtx cui="C0165477" phraseText="trandolaprilat." preferredWord="trandolaprilat" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.2"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.2.e.2"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.4" text="MAVIK is contraindicated in patients who are hypersensitive to this product, in patients with hereditary/idiopathic angioedema and in patients with a history of angioedema related to previous treatment with an ACE inhibitor." type="negative"><entity charOffset="210:223" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.4.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with an ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.4.e.1" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.4.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.4.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5" lineNumber="9" text="Do not co-administer aliskiren with MAVIK in patients with diabetes (see PRECAUTIONS, Drug Interactions)." type="regular"><entity charOffset="0:20" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MAVIK" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:41" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.3" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="aliskiren with MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.0"><relations><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.4" ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.5.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8" text="Presumably because angiotensin converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors, including MAVIK, may be subject to a variety of adverse reactions, some of them serious." type="negative"><entity charOffset="19:59" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.0" text="angiotensin converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="193:198" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.1" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK," preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.2" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.8.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10" lineNumber="19" text="Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. " type="regular"><entity charOffset="0:12" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.0" text="Two patients" type="SPAN"/><entity charOffset="53:70" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.1" text="hymenoptera venom" type="Substance"><Normalization><mmtx cui="C1290000" phraseText="desensitizing treatment with hymenoptera venom" preferredWord="Hymenoptera venom" semType="phsu"/><RxNorm RxCui="390053"/></Normalization></entity><entity charOffset="87:101" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="receiving ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="112:128" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.3" text="life-threatening" type="SPAN"/><entity charOffset="129:152" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.4" text="anaphylactoid reactions" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.1"/></relation><relation type="hasSeverity"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.2" evidence="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.0" severity="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.10.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.17" text="Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with ACE inhibitors including MAVIK. " type="negative"><entity charOffset="139:144" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.17.e.0" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="114:128" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.17.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treated with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.17.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.17.e.0"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.30" text="The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor. " type="negative"><entity charOffset="129:137" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.30.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="resolved after stopping" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="142:155" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.30.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.30.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.30.e.1"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.34" text="Like other ACE inhibitors, MAVIK has only rarely been associated with symptomatic hypotension in uncomplicated hypertensive patients. " type="negative"><entity charOffset="27:32" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.34.e.0" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="11:25" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.34.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Like other ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.34.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.34.e.0"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.41" text="These patients should be followed closely during the first 2 weeks of treatment and, thereafter, whenever the dosage of MAVIK or diuretic is increased. " type="negative"><entity charOffset="129:137" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.41.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="120:125" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.41.e.1" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="the dosage of MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.41.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.41.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.45" lineNumber="41" text="A transient hypotensive response is not a contraindication to further doses; " type="regular"><entity charOffset="12:32" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.45.e.0" text="hypotensive response" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.45.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.45.e.0"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46.e.1"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46" text="however, lower doses of MAVIK or reduced concomitant diuretic therapy should be considered." type="negative"><entity charOffset="24:29" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46.e.0" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="lower doses of MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="53:61" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="reduced concomitant diuretic therapy" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.46.e.1"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.48" text="Another ACE inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression rarely in patients with uncomplicated hypertension, but more frequently in patients with renal impairment, especially if they also have a collagen-vascular disease such as systemic lupus erythematosus or scleroderma. " type="negative"><entity charOffset="23:32" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.48.e.0" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="captopril," preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="8:21" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.48.e.1" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="Another ACE inhibitor," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.48.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.48.e.0"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="168:179" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="198:221" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.2" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.62.e.0"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.75" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals. " type="negative"><entity charOffset="53:64" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.75.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.75.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.75.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.75.e.0"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76" text="In patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with ACE inhibitors, including MAVIK (trandolapril), may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death." type="negative"><entity charOffset="111:122" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.0" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="172:177" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.1" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="99:110" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="179:191" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.3" text="trandolapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0076891" phraseText="(trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="146:160" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.4" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.0"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.3"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.4"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.3"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.3"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.4"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.76.e.3"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.77" text="In hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine have been observed in some patients following ACE inhibitor therapy. " type="negative"><entity charOffset="177:190" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.77.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitor therapy." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="96:100" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.77.e.1" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="increases in blood urea nitrogen" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.77.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.77.e.0"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.78" text="These increases were almost always reversible upon discontinuation of the ACE inhibitor and/or diuretic therapy. " type="negative"><entity charOffset="74:87" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.78.e.0" text="ace inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="almost always reversible upon discontinuation of the ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="95:103" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.78.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.78.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.78.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80" lineNumber="71" text="Some hypertensive patients with no apparent preexisting renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when ACE inhibitors have been given concomitantly with a diuretic. " type="regular"><entity charOffset="185:199" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="237:245" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="concomitantly with a diuretic." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="5:26" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.2" text="hypertensive patients" type="SPAN"/><entity charOffset="94:117" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.3" text="increases in blood urea" type="Specific_Interaction"/><entity charOffset="94:106|122:138" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.5" text="increases in serum creatinine" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.3"><relations><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.5"><relations><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.2" ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.80.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82" lineNumber="71" text="Dosage reduction and/or discontinuation of any diuretic and/or the ACE inhibitor may be required. " type="regular"><entity charOffset="0:16" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.0" text="Dosage reduction" type="Caution_Interaction"/><entity charOffset="24:39" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.2" text="discontinuation" type="Caution_Interaction"/><entity charOffset="47:55" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.4" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of any diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="67:80" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.5" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="the ACE inhibitor" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.5" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.82.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86" text="In clinical trials, hyperkalemia (serum potassium &gt; 6.00 mEq/L) occurred in approximately 0.4% of hypertensive patients receiving MAVIK. " type="negative"><entity charOffset="40:49" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="52:60" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.1" text="6 meq" type="Biomedical_Entity"><Normalization><mmtx cui="C0378958" phraseText="&gt; 6.00 mEq/" preferredWord="6-methoxy-N-ethylquinolinium" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="130:135" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.2" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.2"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.86.e.2"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.87" text="In most cases, elevated serum potassium levels were isolated values, which resolved despite continued therapy. " type="negative"><entity charOffset="30:39" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.87.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="elevated serum potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="52:60" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.87.e.1" text="isolated" type="Biomedical_Entity"><Normalization><mmtx cui="C1875400" phraseText="isolated" preferredWord="ISOLATE COMPOUND" semType="phsu"/><RxNorm RxCui="716166"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.87.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.87.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89" lineNumber="75" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salt substitutes, which should be used cautiously, if at all, with MAVIK. " type="regular"><entity charOffset="124:151" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.0" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="the concomitant use of potassium-sparing diuretics," preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="153:174" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.1" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="36:48" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.2" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="183:220" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.4" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing salt substitutes," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium-containing salt substitutes," preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="271:276" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.5" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="with MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.5" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.5" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.5" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.2" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.4"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.89.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97" lineNumber="83" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, MAVIK will block angiotensin II formation secondary to compensatory renin release. " type="regular"><entity charOffset="96:101" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="47:57|63:94" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.1" text="anesthesia agents that produce hypotension" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="or during anesthesia" preferredWord="Anesthetics" semType="phsu"/><mmtx cui="C1254351" phraseText="with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1021939"/></Normalization></entity><entity charOffset="107:177" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.2" text="block angiotensin II formation secondary to compensatory renin release" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.2"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101" lineNumber="89" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, MAVIK will block angiotensin II formation secondary to compensatory renin release. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0"/></ellipsisSentence><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.98" text="If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion."/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.99" text="Drug Interactions"/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.5"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, MAVIK will block angiotensin II formation secondary to compensatory renin release. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0"/></ellipsisSentence><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.98" text="If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion."/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.99" text="Drug Interactions"/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.ddi.3"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.7"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, MAVIK will block angiotensin II formation secondary to compensatory renin release. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0"/></ellipsisSentence><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.98" text="If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion."/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.99" text="Drug Interactions"/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.ddi.4"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.9"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97" text="In patients undergoing major surgery or during anesthesia with agents that produce hypotension, MAVIK will block angiotensin II formation secondary to compensatory renin release. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.97.e.0"/></ellipsisSentence><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.98" text="If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion."/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.99" text="Drug Interactions"/><middleSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.100" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.0"/><pair ddi="true" e1="labelDrug" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.101.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102" lineNumber="89" text="Closely monitor blood pressure, renal function and electrolytes in patients on MAVIK and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:84" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.2" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="on MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="95:121" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.102.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103" lineNumber="91" text="Do not co-administer aliskiren with MAVIK in patients with diabetes. " type="regular"><entity charOffset="0:20" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.0" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="21:30" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with MAVIK" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:41" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.3" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="aliskiren with MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.0"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.4" ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.103.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104" lineNumber="91" text="Avoid use of aliskiren with MAVIK in patients with renal impairment (GFR &lt;60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:33" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.3" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="with MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="51:67" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.0"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.4" ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.104.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106" lineNumber="95" text="As with other ACE inhibitors, patients on diuretics, especially those on recently instituted diuretic therapy, may experience an excessive reduction of blood pressure after initiation of therapy with MAVIK. " type="regular"><entity charOffset="42:51" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.0" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="patients on diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="200:205" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.1" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="with MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="129:166" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.2" text="excessive reduction of blood pressure" type="Specific_Interaction"/><entity charOffset="14:28" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="As with other ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.1" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.4"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.2"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.106.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107" lineNumber="95" text="The possibility of exacerbation of hypotensive effects with MAVIK may be minimized by either discontinuing the diuretic or cautiously increasing salt intake prior to initiation of treatment with MAVIK. " type="regular"><entity charOffset="60:65" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.0" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="with MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="111:119" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.1" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="35:54" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.2" text="hypotensive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.107.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108" lineNumber="95" text="If it is not possible to discontinue the diuretic, the starting dose of trandolapril should be reduced. " type="regular"><entity charOffset="55:68|95:102" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.0" text="starting dose reduced" type="Caution_Interaction"/><entity charOffset="72:83" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.2" text="trandolapri" type="Drug"><Normalization><mmtx cui="C0076891" phraseText="the starting dose of trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="41:49" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.3" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.3" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.2" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.108.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111" lineNumber="99" text="Trandolapril can attenuate potassium loss caused by thiazide diuretics and increase serum potassium when used alone. " type="regular"><entity charOffset="17:41" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.0" text="attenuate potassium loss" type="Specific_Interaction"/><entity charOffset="52:70" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.2" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="caused by thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:12" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.3" text="Trandolapril" type="Drug"><Normalization><mmtx cui="C0076891" phraseText="Trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.3" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.2" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.111.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="7" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" lineNumber="99" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. " type="regular"><entity charOffset="7:34" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="Use of potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="36:50" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.1" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="(spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="52:63" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.2" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="68:77" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.3" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="80:100" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4" text="potassium supplement" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="106:143" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0351297" phraseText="potassium-containing salt" preferredWord="Potassium salt" semType="inch, phsu"/><mmtx cui="C2757020" phraseText="potassium-containing salt" preferredWord="Potassium Salt [EPC]" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="163:177" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitantly with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="203:215" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.7" text="hyperkalemia" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.1" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0"/><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.2" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0"/><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.3" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.7" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.7" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.7" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113" lineNumber="99" text="If concomitant use of such agents is indicated, they should be used with caution and with appropriate monitoring of serum potassium. " type="irregular"><entity charOffset="63:80" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113.e.0" text="used with caution" type="Caution_Interaction"/><entity charOffset="102:112" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113.e.2" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.113.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.5"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.0"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.6"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112" text="Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.112.e.4"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116" lineNumber="103" text="Concomitant use of ACE inhibitors and antidiabetic medicines (insulin or oral hypoglycemic agents) may cause an increased blood glucose lowering effect with greater risk of hypoglycemia." type="regular"><entity charOffset="19:33" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="Concomitant use of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="38:60" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.1" text="antidiabetic medicines" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="antidiabetic medicines" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C0013227" phraseText="antidiabetic medicines" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.2" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="(insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="(insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="(insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="73:97" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.3" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="173:185" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.6" text="hypoglycemia" type="Specific_Interaction"><Normalization><mmtx cui="C0020615" phraseText="an increased blood glucose lowering effect with greater risk of hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/><mmtx cui="C0020615" phraseText="an increased blood glucose lowering effect with greater risk of hypoglycemia." preferredWord="Hypoglycemia" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.2" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.1"/><classClassMembership drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.3"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.116.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118" lineNumber="107" text="Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. " type="regular"><entity charOffset="0:15|24:30" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.0" text="Increased serum levels" type="Increase_Interaction"/><entity charOffset="55:63" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.2" text="toxicity" type="Increase_Interaction"><Normalization><mmtx cui="C0858786" phraseText="symptoms of lithium toxicity" preferredWord="toxic symptom" semType="sosy"/></Normalization></entity><entity charOffset="16:23" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.4" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><mmtx cui="C0023870" phraseText="Increased serum lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="47:54" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.5" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="symptoms of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="129:142" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitor therapy." preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="117:124" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.7" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="concomitant lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.0"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.4" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.5" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119" lineNumber="107" text="These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. " type="irregular"><entity charOffset="42:49" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119.e.0" text="caution" type="Caution_Interaction"/><entity charOffset="64:74" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119.e.2" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118" text="Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.7"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118" text="Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.119.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118" text="Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.7"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118" text="Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. "><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.118.e.6"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120" lineNumber="107" text="If a diuretic is also used, the risk of lithium toxicity may be increased." type="regular"><entity charOffset="5:13" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="48:56" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="40:47" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.3" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.120.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="59:86" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.0" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><entity charOffset="0:38" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.1" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-Steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="88:104" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.2" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.0"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.121.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122" lineNumber="111" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including trandolapril, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="141:147" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="159:185" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.1" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="192:206" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="20:27" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.3" text="elderly" type="SPAN"/><entity charOffset="29:44" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.4" text="volume-depleted" type="SPAN"/><entity charOffset="92:118" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.5" text="compromised renal function" type="SPAN"/><entity charOffset="218:230" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.7" text="trandolapril" type="Drug"><Normalization><mmtx cui="C0076891" phraseText="trandolapril," preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="246:277" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.9" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="298:317" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.11" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.1"/><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.7" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.2"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.9"><relations><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.11"><relations><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.3, Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.4, Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.5" ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.2" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.122.e.9" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124" lineNumber="111" text="Monitor renal function periodically in patients receiving trandolapril and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:70" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.2" text="trandolapril" type="Drug"><Normalization><mmtx cui="C0076891" phraseText="trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="75:80" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.124.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125" lineNumber="113" text="The antihypertensive effect of ACE inhibitors, including trandolapril may be attenuated by NSAIDs." type="regular"><entity charOffset="4:27|77:87" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.0" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="31:45" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.2" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="The antihypertensive effect of ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="57:69" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.3" text="trandolapril" type="Drug"><Normalization><mmtx cui="C0076891" phraseText="trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="91:97" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.5" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.3" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.2"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.5" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.125.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127" lineNumber="117" text="Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including MAVIK." type="regular"><entity charOffset="0:19" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.0" text="Nitritoid reactions" type="Specific_Interaction"><Normalization><mmtx cui="C0948404" phraseText="Nitritoid reactions" preferredWord="Nitritoid reaction" semType="dsyn"/></Normalization></entity><entity charOffset="160:181" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2" text="sodium aurothiomalate" type="Drug"><Normalization><mmtx cui="C0018034" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold Sodium Thiomalate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="199:212" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3" text="ACE inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="concomitant ACE inhibitor therapy" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="231:236" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.4" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="38:53" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.6" text="facial flushing" type="Specific_Interaction"><Normalization><mmtx cui="C0016382" phraseText="facial flushing," preferredWord="Flushing" semType="sosy"/></Normalization></entity><entity charOffset="55:61" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.8" text="nausea" type="Specific_Interaction"><Normalization><mmtx cui="C0027497" phraseText="nausea," preferredWord="Nausea" semType="sosy"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.10" text="vomiting" type="Specific_Interaction"><Normalization><mmtx cui="C0042963" phraseText="vomiting" preferredWord="Vomiting" semType="sosy"/></Normalization></entity><entity charOffset="76:87" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.12" text="hypotension" type="Specific_Interaction"/><entity charOffset="143:158" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.14" text="injectable gold" type="Drug"><Normalization><mmtx cui="C0018026" phraseText="with injectable gold (sodium aurothiomalate" preferredWord="Gold" semType="phsu, elii"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.4" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3"/><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.14"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.0"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.ddi.2"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.6"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.ddi.3"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.8"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.ddi.4"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.10"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.ddi.5"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.12"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.127.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129" text="No clinically significant pharmacokinetic interaction has been found between trandolaprilat and food, cimetidine, digoxin, or furosemide." type="negative"><entity charOffset="114:121" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.0" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="102:112" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.1" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="cimetidine," preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="77:91" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.2" text="trandolaprilat" type="Biomedical_Entity"><Normalization><mmtx cui="C0165477" phraseText="found between trandolaprilat" preferredWord="trandolaprilat" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="126:136" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.3" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide." preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.0"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.0"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.3"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.1"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.3"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.129.e.3"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.130" text="The anticoagulant effect of warfarin was not significantly changed by trandolapril." type="negative"><entity charOffset="28:36" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.130.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="The anticoagulant effect of warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="70:82" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.130.e.1" text="trandolapril" type="Biomedical_Entity"><Normalization><mmtx cui="C0076891" phraseText="changed by trandolapril." preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.130.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.130.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131" lineNumber="125" text="The hypotensive effect of certain inhalation anesthetics may be enhanced by ACE inhibitors including trandolapril (see PRECAUTIONS-Surgery/Anesthesia)." type="regular"><entity charOffset="76:90" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.0" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="enhanced by ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="101:113" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.1" text="trandolapril" type="Drug"><Normalization><mmtx cui="C0076891" phraseText="trandolapril" preferredWord="trandolapril" semType="phsu, orch"/><RxNorm RxCui="38454"/></Normalization></entity><entity charOffset="34:56" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.3" text="inhalation anesthetics" type="Drug_Class"><Normalization><mmtx cui="C0242903" phraseText="The hypotensive effect of certain inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="4:22|64:72" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.4" text="hypotensive effect enhanced" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.1" drugClass="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.0"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.4"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.3" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.0" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.131.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.134" text="The recommended initial dosage of MAVIK for patients not receiving a diuretic is 1 mg once daily in non-black patients and 2 mg in black patients. " type="negative"><entity charOffset="34:39" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.134.e.0" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="The recommended initial dosage of MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.134.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.134.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.134.e.1"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.140" text="If blood pressure is not adequately controlled with MAVIK monotherapy, a diuretic may be added." type="negative"><entity charOffset="73:81" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.140.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="a diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="52:57" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.140.e.1" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="controlled with MAVIK monotherapy," preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.140.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.140.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141" lineNumber="135" text="In patients who are currently being treated with a diuretic, symptomatic hypotension occasionally can occur following the initial dose of MAVIK. " type="regular"><entity charOffset="51:59" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="treated with a diuretic, symptomatic hypotension occasionally" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="138:143" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.1" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="the initial dose of MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="61:84" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.2" text="symptomatic hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.141.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.142" text="To reduce the likelihood of hypotension, the diuretic should, if possible, be discontinued two to three days prior to beginning therapy with MAVIK. " type="negative"><entity charOffset="45:53" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.142.e.0" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="141:146" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.142.e.1" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="with MAVIK." preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.142.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.142.e.1"/></sentence><sentence id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.144" text="Then, if blood pressure is not controlled with MAVIK alone, diuretic therapy should be resumed. " type="negative"><entity charOffset="47:52" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.144.e.0" text="mavik" type="Biomedical_Entity"><Normalization><mmtx cui="C0721596" phraseText="controlled with MAVIK alone, diuretic therapy" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="60:68" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.144.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="controlled with MAVIK alone, diuretic therapy" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.144.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.144.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145" lineNumber="135" text="If the diuretic cannot be discontinued, an initial dose of 0.5 mg MAVIK should be used with careful medical supervision for several hours until blood pressure has stabilized. " type="regular"><entity charOffset="7:15" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.0" text="diuretic" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="66:71" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.1" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="an initial dose of 0.5 mg MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="108:119" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.2" text="supervision" type="Caution_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.2"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.145.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148" lineNumber="137" text="Concomitant administration of MAVIK with potassium supplements, potassium salt substitutes, or potassium sparing diuretics can lead to increases of serum potassium. " type="regular"><entity charOffset="30:35" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.0" text="MAVIK" type="Drug"><Normalization><mmtx cui="C0721596" phraseText="Concomitant administration of MAVIK" preferredWord="Mavik" semType="phsu, orch"/><RxNorm RxCui="218245"/></Normalization></entity><entity charOffset="41:62" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.1" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="with potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="64:90" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.2" text="potassium salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="potassium salt substitutes," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="potassium salt substitutes," preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="95:122" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.3" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="135:163" id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.4" text="increases of serum potassium" type="Specific_Interaction"/><drugInteraction id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.ddi.1"><interaction trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.4"><relations><relation type="hasObject"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.1" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.2" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.4" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.0" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.3" trigger="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.4" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.2"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.1" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.3"/><pair ddi="false" e1="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.2" e2="Dailymed.5ad67ea2-409c-4f52-a9b8-38216209609a.s.148.e.3"/></sentence><positiveExamples number="35"/><negativeExamples number="58"/></document>